The diagnostic performance of afamin plus the BMI was also verified in biopsy-proven participants, and it was found that the BMI plus afamin had a high accuracy for the diagnosis of NAFLD. The gene discussed is AFM; the disease is metabolic dysfunction-associated steatotic liver disease.